Nonencapsulated Streptococcus pneumoniae resists extracellular human neutrophil elastase- and cathepsin G-mediated

Dieke van der Windt1, Hester J Bootsma, Peter Burghout

  • 1Laboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands.

Insights

Nonencapsulated Streptococcus pneumoniae show increased resistance to neutrophil proteases like elastase and cathepsin G. This enhanced survival is crucial for mucosal infections, impacting bacterial virulence.

Area of Science:

  • Microbiology
  • Immunology
  • Bacterial Pathogenesis

Background:

  • The polysaccharide capsule of Streptococcus pneumoniae is a key virulence factor.
  • Approximately 15% of S. pneumoniae carriage isolates are nonencapsulated and cause mucosal infections.
  • Neutrophils utilize proteases (elastase, cathepsin G) and antimicrobial peptides for bacterial killing.

Purpose of the Study:

  • To investigate the differential resistance of nonencapsulated and encapsulated S. pneumoniae to neutrophil-mediated killing.
  • To assess the role of extracellular neutrophil proteases in the survival of nonencapsulated pneumococci.

Main Methods:

  • Comparative analysis of nonencapsulated and encapsulated S. pneumoniae.
  • In vitro assays measuring bacterial killing by human neutrophil elastase and cathepsin G.
  • Evaluation of resistance to cationic antimicrobial peptides.

Main Results:

  • Nonencapsulated S. pneumoniae exhibit significantly greater resistance to killing by extracellular human neutrophil elastase and cathepsin G compared to encapsulated strains.
  • This enhanced protease resistance is a notable characteristic of nonencapsulated pneumococci.

Conclusions:

  • Nonencapsulated S. pneumoniae possess enhanced resistance to key extracellular neutrophil proteases.
  • This protease resistance is likely a critical factor for the survival and pathogenesis of nonencapsulated strains at mucosal surfaces.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...